AzTrials
AzTrials

Emergency DepartmentNCT07111624

A New Crowding Indicator in the Emergency Department

An observational study of Emergency Department and Crowding, run by Mario Negri Institute for Pharmacological Research at 52 sites in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Fenice has proposed a new indicator to measure the level of crowding in the ER. The aim of this study is to evaluate, in a national multicenter context, the degree of agreement between the Fenice indicator and the perception of crowding of the ER operators and to compare this agreement with that between NEDOCS and the… Read more about this study

Who is it for?
Any age
Conditions the study is for
Emergency Department, Crowding
How many people
828 participants
Where
52 sitesItaly
Study dates
15 Oct 2025to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients arriving in the emergency department at the time of the survey.

Who may be able to join

  • Patients that are in EDs at the time of the survey

Who cannot join

  • Patients that are in EDs, but not at the time of the survey

Trial locations and contacts

52 sites in 1 country.

52 sites in 1 country

Italy52 sites
  • AOU SS. Antonio e Biagio e Cesare Arrigo

    Alessandria

  • Ospedale Regionale Umberto Parini

    Aosta

  • Ospedale San Bassiano

    Bassano del Grappa

  • Humanitas Gavazzeni

    Bergamo

  • Ospedale Papa Giovanni XXIII

    Bergamo

  • Ospedale Maggiore "CA Pizzardi"

    Bologna

  • Policlinico Sant'Orsola Malpighi

    Bologna

  • Spedali civili

    Brescia, BS

  • AOU Policlinico San Marco-PO Gaspare Rodolico

    Catania

  • AOU Policlinico San Marco-PO San Marco

    Catania

  • Ospedale Civico

    Chivasso

  • ASST Nord Milano P.O. Bassini

    Cinisello Balsamo

  • Presidio Osped. Riunito

    Cirié, TO

  • PO di Codogno

    Codogno

  • Ospedale Valduce

    Como

  • IRCCS San Martino

    Genova, GE

  • Ospedale G. B. Grassi

    Lido di Ostia

  • Ospedale Maggiore

    Lodi

  • Ospedale Carlo Poma

    Mantua

  • Ospedale Madonna delle Grazie

    Matera

  • ASST Ca' Granda Niguarda

    Milan

  • ASST Fatebenefratelli Sacco, P.O. Luigi Sacco

    Milan

  • IRCCS Ospedale San Raffaele

    Milan

  • Ospedale Fatebenefratelli e Oftalmico

    Milan

  • Ospedale San Paolo

    Milan

  • Policlinico di Milano Ospedale Maggiore

    Milan

  • Policlinico di Monza

    Monza

  • AOU Maggiore della Carità

    Novara

  • AOU San Luigi Gonzaga

    Orbassano, TO

  • Ospedale E. Agnelli

    Pinerolo

  • Ospedale Santa Maria degli Angeli

    Pordenone

  • Ospedale Santa Maria delle Grazie

    Pozzuoli

  • Ospedale Santa Maria delle Croci

    Ravenna, RA

  • Ospedale Infermi

    Rimini

  • Ospedale degli Infermi

    Rivoli

  • Azienda Ospedaliera San Camillo Forlanini

    Roma, RM

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma

  • Policlinico Tor Vergata

    Roma

  • Presidio Ospedaliero San Filippo Neri

    Roma

  • Ospedale Città del Piave

    San Donà di Piave

  • Ospedale Santa Maria dei Battuti

    San Vito al Tagliamento

  • Ospedale Savigliano e Saluzzo

    Savigliano

  • Ospedale Città di Sesto San Giovanni

    Sesto San Giovanni

  • Ospedale di Spilimbergo

    Spilimbergo

  • Presidio Ospedaliero S'Antonio Abate

    Tolmezzo

  • AO Ordine Mauriziano

    Torino

  • Humanitas Gradenigo

    Torino

  • Ospedale Molinette

    Torino

  • Ospedale San Giovanni Bosco

    Torino

  • Ospedale Santa Chiara

    Trento

  • Ospedale di Circolo

    Varese

  • P.O. Sant'Andrea

    Vercelli, VC

Other trials in Italy

About this study

Official title: Comparison Between a New Crowding Indicator and the Perception of Healthcare Workers in the Emergency Department

Fenice has proposed a new indicator to measure the level of crowding in the ER. The aim of this study is to evaluate, in a national multicenter context, the degree of agreement between the Fenice indicator and the perception of crowding of the ER operators and to compare this agreement with that between NEDOCS and the perception of the operators.

Read the detailed description

The NEDOCS (National Emergency Department OverCrowding Study) is currently the most widely used indicator in Italy to measure the level of crowding in Emergency Departments (EDs). However, despite its widespread use, it presents several critical issues. First of all, it was developed in a context very different from the current Italian one, since it was built on data collected in 2002 in 8 medium-large US university EDs. It is therefore not possible to take for granted that this indicator can accurately describe the current crowding conditions of Italian EDs. Furthermore, the factors that make up the NEDOCS are often calculated differently by the various hospital facilities, compromising the comparability of the estimates.

Fenice has proposed a new indicator to measure the level of crowding in EDs. The indicator was developed to measure one of the objective consequences of crowding in EDs, namely the increase in waiting time for patients with a problem classified as minor urgency or deferrable to triage (codes 3 and 4). In parallel, the Fenice study has shown that NEDOCS is not very sensitive to this objective consequence of crowding.

The aim of this study is to evaluate, in a national multicenter context, the degree of agreement between the Fenice indicator and the perception of crowding of the operators of the ER and to compare this agreement with that between NEDOCS and the perception of the operators.

Medical subject headings
Emergencies, Crowding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07111624
Study groupRoleWhat they receive
Elegible populationAll patients arrived in ED during the year 2024 and patientes arrived in the period of active monitoring of the perception of crowding.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of variation in the ED staff perceived crowding level that is explained by the Fenice crowding score.

    The outcome will be measured using the coefficient of determination (referred to as R2) of the linear model regressing the perceived level of crowding on the Fenice score.

    Measured: September 2025 - December 2025

Secondary outcomes (1)
  1. Proportion of variation in the ED staff perceived crowding level that is explained by the NEDOCS score, measured using the coefficient of determination (R2) of the linear model regressing the perceived level of crowding on the NEDOCS score.

    Measured: September 2025 - December 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2025
  2. Study start15 Oct 2025
  3. Primary completion13 Dec 2025
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
828 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07111624
Sponsor's protocol ID
CAOS
Status last verified
May 2026
First submitted
23 Jul 2025
Last updated
20 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Department and Crowding, run by Mario Negri Institute for Pharmacological Research at 52 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 52 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of variation in the ED staff perceived crowding level that is explained by the Fenice crowding score. (time frame: September 2025 - December 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in